查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1939210

2026年全球α辐射源市场报告

Alpha Emitter Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，α放射性核种市场呈指数级成长，预计将从2025年的16.1亿美元成长到2026年的19.9亿美元，复合年增长率达23.6%。迄今为止的增长可归因于多种因素，包括α放射性核素供应有限、对铀和镭等天然资源的依赖、人们对标靶癌症治疗的认识不断提高、早期临床试验的出现以及生产基础设施的缺乏。

预计未来几年，α发射体市场将呈指数级成长，到2030年市场规模将达到46亿美元，复合年增长率（CAGR）为23.3%。预测期内的成长要素包括人工放射性核种生产设施的建设、肿瘤治疗投资的增加、骨转移和前列腺癌治疗中α发射体应用的日益普及、靶向α疗法技术的进步以及在医学研究领域应用的不断拓展。预测期内的主要趋势包括α发射体在治疗方法中的应用日益广泛、放射性核素生产和分离研究的不断深入、人工生产的α发射体数量的增长、α发射体在肿瘤治疗领域之外的治疗应用拓展，以及对放射性物质处理安全性和合规性的日益重视。

预计未来几年癌症发生率的上升将推动α发射体市场的成长。癌症是一种异常细胞在体内不受控制地生长和扩散，形成肿瘤并侵袭周围组织的疾病。导致癌症发生率上升的因素包括人口老化、环境暴露、生活方式改变以及检测方法的进步。 α发射体用于癌症治疗，能够精准靶向并摧毁癌细胞，同时最大限度地减少对周围正常组织的损伤。例如，总部位于瑞士的国际组织－世界卫生组织（WHO）于2024年2月预测，2050年，全球将新增超过3,500万例癌症病例，比2022年估计的2,000万例成长77%。因此，癌症发生率的上升正在推动α发射体市场的成长。

为了增强自身竞争优势，α放射性核种市场的企业正在投资创新解决方案，例如迴旋加速器生产的α放射性核种。迴旋加速器产生的α放射性核素是崩坏时会释放α粒子的放射性同位素，其生产方法是在迴旋加速器中将带电粒子加速到高能量。例如，2023年4月，总部位于美国的迴旋加速器和科技公司Ionetix在其位于密西根州兰辛市的新建α同位素生产设施中成功生产了首个α放射性核种－砹-211（At-211）。该设施是美国第一个专门利用迴旋加速器技术生产α放射性核种的设施。透过调试一台 30 MeV 迴旋加速器，实现了高产率的砹-211 (At-211) 和锕-225 (试运行-225) 的生产。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球α辐射源市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 永续性、气候技术和循环经济
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 扩大α粒子发射体癌症治疗方法的应用
    • 加强对放射性核种生产与分离的研究力度
    • 人工产生的α发射体增加
    • 拓展肿瘤学以外的应用
    • 更重视放射性物质处理过程中的安全与法规遵循

第五章 终端用户产业市场分析

  • 医院
  • 医学研究所
  • 肿瘤诊所
  • 製药公司
  • 核子医学检查室

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球α辐射源市场：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球α辐射源市场规模、比较及成长率分析
  • 全球α辐射源市场表现：规模与成长，2020-2025年
  • 全球α辐射源市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按放射性核种类型
  • 镭、锕、铅、铋和其他放射性核种
  • 按来源
  • 天然的、人工生产的和其他来源
  • 透过使用
  • 胰臟癌、卵巢癌、摄护腺癌、淋巴瘤、黑色素瘤、骨转移及其他适应症
  • 最终用户
  • 医院、医学研究机构和其他最终用户
  • 按类型细分：镭
  • 镭-223、镭-226、镭-228
  • 按类型细分：锕系元素
  • 锕-227，锕-225
  • 按类型细分：潜在客户
  • 铅-210，铅-212
  • 按类型细分：铋
  • 铋-213，铋-212
  • 按类型细分：其他放射性核素
  • 钍、钋、鍅

第十章 区域与国家分析

  • 全球α辐射源市场：依地区、性能及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球α辐射源市场：依国家划分，实际结果及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • α射线源市场：竞争格局及市场占有率（2024年）
  • α辐射源市场：公司估值矩阵
  • α辐射源市场：公司概况
    • Bayer AG
    • Lantheus Holdings Inc.
    • Curium Pharma
    • Eckert & Ziegler BEBIG GmbH
    • Telix Pharmaceuticals Limited

第37章：其他领先和创新企业

  • NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, TAE Life Sciences, Fusion Pharmaceuticals Inc., Alpha Tau Medical Ltd., Alpha-9 Oncology, Aktis Oncology, Abdera Therapeutics

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年α辐射源市场：提供新机会的国家
  • 2030年α辐射源市场：蕴藏新机会的细分市场
  • 2030年α辐射源市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MAEMI02_G26Q1

An alpha emitter is a form of radioactive material that releases alpha particles during radioactive decay. It includes elements such as uranium, radium, and plutonium, which undergo alpha decay as part of natural radioactive processes. Alpha emitters are important in medical treatments, particularly cancer therapy, and have applications in technologies like smoke detectors and space exploration.

The main radionuclides of alpha emitters include radium, actinium, lead, bismuth, and others. Radium is a radioactive substance used in both therapeutic and diagnostic medical procedures. The sources include natural origins, artificially produced sources, and others, while the applications include pancreatic cancer, ovarian cancer, prostate cancer, lymphoma, melanoma, bone metastasis, and others. They are used across various end-users such as hospitals, medical research organizations, and others.

Tariffs have influenced the alpha emitter market by increasing costs for imported radionuclides and production equipment, particularly affecting segments like radium-223, actinium-225, and bismuth-213. Asia-Pacific regions, including China and India, are highly impacted due to import dependencies. While tariffs raise production costs and may slow supply chains, they also incentivize local production, research investment, and development of alternative radionuclide sources, supporting long-term market growth.

The alpha emitter market research report is one of a series of new reports from The Business Research Company that provides alpha emitter market statistics, including alpha emitter industry global market size, regional shares, competitors with a alpha emitter market share, detailed alpha emitter market segments, market trends and opportunities, and any further data you may need to thrive in the alpha emitter industry. This alpha emitter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alpha emitter market size has grown exponentially in recent years. It will grow from $1.61 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to limited availability of alpha-emitting radionuclides, reliance on natural sources like uranium and radium, growing awareness of targeted cancer therapies, emergence of early clinical trials, limited production infrastructure.

The alpha emitter market size is expected to see exponential growth in the next few years. It will grow to $4.6 billion in 2030 at a compound annual growth rate (CAGR) of 23.3%. The growth in the forecast period can be attributed to development of artificial radionuclide production facilities, rising investment in oncology treatments, increasing adoption in bone metastasis and prostate cancer therapies, advancement in targeted alpha therapy technologies, expanding medical research applications. Major trends in the forecast period include rising adoption of alpha-emitter-based cancer therapies, increased research in radionuclide production and isolation, growth in artificially produced alpha emitters, expansion of therapeutic applications beyond oncology, enhanced focus on safety and regulatory compliance for handling radioactive materials.

The growing prevalence of cancer is expected to drive the growth of the alpha emitter market in the coming years. Cancer is a disease characterized by the uncontrolled proliferation and spread of abnormal cells within the body, which can form tumors and invade surrounding tissues. The increasing prevalence of cancer is influenced by factors such as aging populations, environmental exposure, lifestyle changes, and advancements in detection methods. Alpha emitters are used in cancer therapy to precisely target and destroy tumor cells while minimizing damage to nearby healthy tissues. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, there will be more than 35 million new cancer cases worldwide, representing a 77% increase compared with the estimated 20 million cases recorded in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the alpha emitter market.

Companies operating in the alpha-emitter market are investing in innovative solutions, such as alpha-emitting radionuclides produced using cyclotrons, to strengthen their competitive positioning. Alpha-emitting radionuclides generated using cyclotrons are radioactive isotopes that emit alpha particles during decay, produced by accelerating charged particles to high energies within a cyclotron. For example, in April 2023, Ionetix, a US-based cyclotron and technology company, produced its first alpha-emitting radionuclide, Astatine-211 (At-211), at its newly established Alpha Isotope Manufacturing facility in Lansing, Michigan. This facility is notable for being the first in the US dedicated exclusively to producing alpha-emitting radionuclides using cyclotron technology. Production was achieved through the commissioning of a 30 MeV cyclotron designed to accelerate alpha particles for high-yield generation of At-211 and Actinium-225 (Ac-225).

In February 2024, Bristol-Myers Squibb Co. (BMS), a US-based biopharmaceutical company, acquired RayzeBio, Inc. for $4.1 billion. With this acquisition, Bristol-Myers Squibb Co. enhances its oncology portfolio by adding innovative radiopharmaceutical therapies, particularly targeted alpha-emitter treatments. RayzeBio Inc. is a US-based provider of alpha-emitter technologies.

Major companies operating in the alpha emitter market are Bayer AG, Lantheus Holdings Inc., Curium Pharma, Eckert & Ziegler BEBIG GmbH, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, TAE Life Sciences, Fusion Pharmaceuticals Inc., Alpha Tau Medical Ltd., Alpha-9 Oncology, Aktis Oncology, Abdera Therapeutics, Oncoinvent ASA, Theragnostics Ltd., ARICEUM Therapeutics, Sirius Medical Systems B.V.

North America was the largest region in the alpha emitter market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha emitter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alpha emitter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The alpha emitter market consists of sales of Plutonium-238 (Pu-238), Thorium-227 (Th-227), Polonium-210 (Po-210), and Americium-241 (Am-241). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alpha Emitter Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses alpha emitter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alpha emitter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The alpha emitter market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type Of Radionuclide: Radium; Actinium; Lead; Bismuth; Other Types Of Radionuclides
  • 2) By Source: Natural Sources; Artificially Produced Sources; Other Sources
  • 3) By Application: Pancreatic Cancer; Ovarian Cancer; Prostate Cancer; Lymphoma; Melanoma; Bone Metastasis; Other Applications
  • 4) By End-User: Hospitals; Medical Research Institutions; Other End-Users
  • Subsegments:
  • 1) By Radium: Radium-223; Radium-226; Radium-228
  • 2) By Actinium: Actinium-227; Actinium-225
  • 3) By Lead: Lead-210; Lead-212
  • 4) By Bismuth: Bismuth-213; Bismuth-212
  • 5) By Other Types of Radionuclides: Thorium; Polonium; Francium
  • Companies Mentioned: Bayer AG; Lantheus Holdings Inc.; Curium Pharma; Eckert & Ziegler BEBIG GmbH; Telix Pharmaceuticals Limited; NorthStar Medical Radioisotopes LLC; ITM Isotope Technologies Munich SE; International Isotopes Inc.; IBA Radiopharma Solutions; Orano Med LLC; Actinium Pharmaceuticals Inc.; Clarity Pharmaceuticals Ltd.; RadioMedix Inc.; Nordic Nanovector ASA; TAE Life Sciences; Fusion Pharmaceuticals Inc.; Alpha Tau Medical Ltd.; Alpha-9 Oncology; Aktis Oncology; Abdera Therapeutics; Oncoinvent ASA; Theragnostics Ltd.; ARICEUM Therapeutics; Sirius Medical Systems B.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Alpha Emitter Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Alpha Emitter Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Alpha Emitter Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Alpha Emitter Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Alpha-Emitter-Based Cancer Therapies
    • 4.2.2 Increased Research In Radionuclide Production And Isolation
    • 4.2.3 Growth In Artificially Produced Alpha Emitters
    • 4.2.4 Expansion Of Therapeutic Applications Beyond Oncology
    • 4.2.5 Enhanced Focus On Safety And Regulatory Compliance For Handling Radioactive Materials

5. Alpha Emitter Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Medical Research Institutions
  • 5.3 Oncology Clinics
  • 5.4 Pharmaceutical Companies
  • 5.5 Nuclear Medicine Laboratories

6. Alpha Emitter Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Alpha Emitter Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Alpha Emitter PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Alpha Emitter Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Alpha Emitter Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Alpha Emitter Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Alpha Emitter Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Alpha Emitter Market Segmentation

  • 9.1. Global Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radium, Actinium, Lead, Bismuth, Other Types Of Radionuclides
  • 9.2. Global Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Natural Sources, Artificially Produced Sources, Other Sources
  • 9.3. Global Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pancreatic Cancer, Ovarian Cancer, Prostate Cancer, Lymphoma, Melanoma, Bone Metastasis, Other Applications
  • 9.4. Global Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Medical Research Institutions, Other End-Users
  • 9.5. Global Alpha Emitter Market, Sub-Segmentation Of Radium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radium-223, Radium-226, Radium-228
  • 9.6. Global Alpha Emitter Market, Sub-Segmentation Of Actinium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Actinium-227, Actinium-225
  • 9.7. Global Alpha Emitter Market, Sub-Segmentation Of Lead, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lead-210, Lead-212
  • 9.8. Global Alpha Emitter Market, Sub-Segmentation Of Bismuth, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bismuth-213, Bismuth-212
  • 9.9. Global Alpha Emitter Market, Sub-Segmentation Of Other Types Of Radionuclides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Thorium, Polonium, Francium

10. Alpha Emitter Market Regional And Country Analysis

  • 10.1. Global Alpha Emitter Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Alpha Emitter Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Alpha Emitter Market

  • 11.1. Asia-Pacific Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Alpha Emitter Market

  • 12.1. China Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Alpha Emitter Market

  • 13.1. India Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Alpha Emitter Market

  • 14.1. Japan Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Alpha Emitter Market

  • 15.1. Australia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Alpha Emitter Market

  • 16.1. Indonesia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Alpha Emitter Market

  • 17.1. South Korea Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Alpha Emitter Market

  • 18.1. Taiwan Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Alpha Emitter Market

  • 19.1. South East Asia Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Alpha Emitter Market

  • 20.1. Western Europe Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Alpha Emitter Market

  • 21.1. UK Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Alpha Emitter Market

  • 22.1. Germany Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Alpha Emitter Market

  • 23.1. France Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Alpha Emitter Market

  • 24.1. Italy Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Alpha Emitter Market

  • 25.1. Spain Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Alpha Emitter Market

  • 26.1. Eastern Europe Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Alpha Emitter Market

  • 27.1. Russia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Alpha Emitter Market

  • 28.1. North America Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Alpha Emitter Market

  • 29.1. USA Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Alpha Emitter Market

  • 30.1. Canada Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Alpha Emitter Market

  • 31.1. South America Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Alpha Emitter Market

  • 32.1. Brazil Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Alpha Emitter Market

  • 33.1. Middle East Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Alpha Emitter Market

  • 34.1. Africa Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Alpha Emitter Market Regulatory and Investment Landscape

36. Alpha Emitter Market Competitive Landscape And Company Profiles

  • 36.1. Alpha Emitter Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Alpha Emitter Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Alpha Emitter Market Company Profiles
    • 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Telix Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

37. Alpha Emitter Market Other Major And Innovative Companies

  • NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, TAE Life Sciences, Fusion Pharmaceuticals Inc., Alpha Tau Medical Ltd., Alpha-9 Oncology, Aktis Oncology, Abdera Therapeutics

38. Global Alpha Emitter Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Alpha Emitter Market

40. Alpha Emitter Market High Potential Countries, Segments and Strategies

  • 40.1 Alpha Emitter Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Alpha Emitter Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Alpha Emitter Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer